factual

23andMe Offered Genetics Value Despite FDA Clash

23andMe collided with the FDA and was shut down partly because it launched an aggressive multi-million-dollar marketing campaign while being unresponsive to FDA correspondence, but its $99 service offering pharmacogenomic information on ~30 commonly used drugs was a genuine bargain, and direct-to-consumer genomics is acceptable as long as the data and interpretation are accurate and validated.

factualpending

Speaker

Eric Topol

Evidence Quote

“they weren't responsive to FDA correspondence and communication, they were shut down. Not a good idea, to have a multi-million marketing campaign and not to respond to the FDA.”

Source

Eric Topol on the Power of Patients in a Digital World— EconTalk
Created: 6/13/2026, 12:17:22 AM

Your notes

Loading notes...